Real Brands Inc (RLBD)

[sweet crude]

RLBD Issued .10 to .15 target (read)

I think this is way low, and could easily run to .20+ once things start rolling out, but .10 to .15 here seems very realistic. Trying to free up some cash on other junk plays to grab bit more donw here...no brainer!

Real Brands (RLBD) Cannabis Acquisitions Prompts Upgrade

(NEW YORK)–Real Brands, Inc. (OTC:RLBD), a portfolio of consumer-packaged goods and brands, looks to become a sort of Amazon dotcom of cannabis related consumer products with their acquisition of CBD Pharmacy.

The Company recently announced they have signed a binding letter of intent with CBD Pharmacy, Inc. to acquire the CBD Pharmacy™ trademark plus four (4) US utility patents for the manufacturer of consumable legal cannabis and hemp products as defined by the states on a state-by-state basis. In addition RLBD has also agreed to acquire four (4) Colorado trademarks for use in legal cannabis and hemp products.

Recent Upgrade to Stock

Ludlow Research, a small cap equity research firm out of New York City, recently made note of both RLBD acquisition of CBD Pharmacy, the Omega Hemp Water brand, and low market cap valuation as reason for launching their coverage.

Report Highlights

– Pending Acquisition of CBD Pharmacy
– To Leverage Trademark with Licensed Distributors
– Royalty Fee Income from other Distributors
– Omega Hemp Water Production Infrastructure in Place
– First Production Run Expected in Q3 2017
– 30 Years Experience in Beverage Industry
– 70 Million Shares Outstanding
– Public Float just over 7 Million
– Low Market Valuation for Sector

Related: RLBD Discusses First Omega Hemp Water Production in Q3

As of June 2017, the Company had roughly 70 million common shares issued and outstanding, with a public float of just around 7 million shares. Based on their current projects focused on the cannabis sector, pending royalty fees from CBD Pharmacy, first production run of Omega Hemp Water expected in Q3, and low public float, Ludlow Research has initiated coverage on company with a ‘speculative’ short-term valuation target of $0.10 to $0.15 per share.

http://www.wallstreetnewscast.com/rlbd-0620/